News & Announcements

Acquisition of Archipelago Aquiculture Group (“AAG”)

Ross Group Plc (LSE: RGP) is pleased to announce that it has, as of January 2019, completed the acquisition of the entire issued share capital of Archipelago Aquaculture Group LLC. (“AAG”) from Global Blue Technologies Group, Inc (“GBTGI”) (the “Acquisition”) and is planning to start producing revenue in the near future, having already achieved proof of concept in its specialized extraction of Chitin, which is understood to be one of the most environmentally-friendly and economically effective extraction processes within the industry. 

GBTGI and its affiliate subsidiaries are an international Group of companies that have created the world’s first commercially viable bio-secure recyclable aquaculture system (“RAS”) for the production of high quality, high value and accredited best-tasting organic colossal and extra colossal shrimp. AAG contains the start-up businesses of Mari Signum Limited, Mari Signum Dragon Drying-MS LLC, Mari Signum Mid-Atlantic LLC and Prometheus Progeniture Genetics Technologies Limited LLC, which are all specific supply chain companies involved in the research, development and production of Chitin, one of the main component in the exoskeletons of crustaceans and other arthropods. 

Chitin is a natural bio-degradable polymer with the potential to transform the plastics, agricultural, veterinary, textile, cosmetic and pharmaceutical industries. AAG intends to focus on providing the highest possible quality Chitin to targeted pharmaceutical customers on a very selective strategic basis. Chitin is found in the exoskeletons of arthropods (shrimp, crab, lobster, insects), and is one of the most abundant, organic bio-polymers found in nature (second to cellulose). Polymers are chains of molecules, the makeup of which determines the characteristics and beneficial properties of the materials in which the polymers are found: stiffness, strength, elasticity and toughness – as well as health, environmental and therapeutic benefits. Chitin is a stable bio-polymer that is fully biodegradable with the potential to replace standard petrochemical plastic. Its unique molecular properties can be harnessed to innovate and revolutionize industries such as biotech, industrial filtration, medical and textiles. 

Mari Signum is a chitin and chitin derivative production/processing company using a proprietary ionic liquid extraction process. It is the only commercially viable, environmentally responsible and U.S. government approved process for extracting high-quality chitin supplied by nature.

Dream ESG Investment

  • Nontoxic proprietary extraction methods -Chitin’s bio-polymer will impact the human world in beneficial ways 
  • A company guided by the ‘Triple Bottom Line’ of environmental stewardship, social equity and ethical capitalism. 
  • Run by competent and conscientious local management 
  • High growth with high margins expected 
  • Mari Signum has the proprietary technologies to dry shell biomass materials locally, eliminating the wasteful disposal of decaying shrimp shells collected as industrial waste

2018 Green Chemistry Award

Mari Signum has received the prestigious 2018 Green Chemistry Challenge Award from the U.S. Environmental Protection Agency (EPA) in recognition of its unique technology that allows the sustainable isolation & extraction of the chitin polymer from crustacean shell biomass. The Green Chemistry Challenge Award program is in partnership with the American Chemical Society (ACS), and past winners of this annual EPA award include Merck, Amgen, Dow Chemical, Kraton Performance Polymers, Codexis, BASF, Dupont, Cargill and Bayer Corporation.

Mari Signum Business Strategy

Mari Signum Mid-Atlantic LLC, is based in Richmond, VA, U.S.A. The current facility has the ability to expand production as the market demand grows. Mari Signum is strategically positioned with shell biomass supply from partnerships with Global Blue Technologies as well as sourcing from 3rd parties. Mari Signum will produce the world’s highest quality chitin from the GBT shell biomass, unlocking high end markets in bio pharma, medical and dental industries.

Ross Group Plc is positioned to create a sustainable bio-polymer solution for the world.

AGM 2018 Documents

AGM Notice 2018

Proxy Form

Dec 2017 Final Accounts